Skip to content
GK24

ICAR-NIHSAD Develops India's First Indigenous H5N1 Vaccine

ICAR-NIHSAD Bhopal has made India's first indigenous inactivated H5N1 Clade 2.3.2.1a bird flu vaccine for chickens, to be dedicated on 20 November 2026.

By Published · 2 min read
ICAR-NIHSAD Develops India's First Indigenous H5N1 Vaccine — GK24 title card

Why in News

On 18 November 2026 the Ministry of Agriculture and Farmers Welfare said that India's first indigenous inactivated H5N1 Clade 2.3.2.1a vaccine for chickens, developed by ICAR-NIHSAD Bhopal, will be dedicated to the nation on 20 November 2026.

India now has a vaccine of its own against the strain of bird flu that has hurt its poultry farms the most. The ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) at Bhopal has built an inactivated vaccine for chickens that works against H5N1 Clade 2.3.2.1a, the Highly Pathogenic Avian Influenza (HPAI) virus behind most outbreaks in chicken flocks. Nothing of this kind had been made in the country before. Union Minister of Agriculture and Farmers Welfare and Rural Development Shivraj Singh Chouhan is to dedicate it to the nation at the Bhopal institute on 20 November 2026.

Why this clade needed a vaccine

Work on the virus has pinned most chicken outbreaks on Clade 2.3.2.1a. The strain has lately been picked up in a range of animals, mammals included, and in three people. Until now no commercial vaccine aimed at this clade was available anywhere, so a home-grown one was the only way for India to cover the gap. The new vaccine is meant to shield birds from the Clade 2.3.2.1a viruses in circulation in the country.

What an outbreak costs

Bird flu, as HPAI is usually called, can kill nearly every infected bird, with deaths touching 100 per cent of a flock. The farmer loses twice over, first when birds are culled in bulk and again when trade curbs follow. Product prices, export business and rural livelihoods all move with it. The disease was first picked up in India in 2006, and the country has since logged more than 500 outbreaks of the H5N1 and H5N8 subtypes taken together.

Figures worth memorising

Possible loss of GDP growth in a big outbreakUp to 1.5 per cent
Poultry population at risk if the disease is uncheckedOver 20 per cent
Estimated loss in the 2006 outbreakRs 2,200 to 3,000 crore
Loss in the Manipur outbreak0.5 per cent of that state's GDP
WHO tally of human cases since 20031,003 cases, 479 deaths, 25 countries

A public health question too

Health agencies keep a close watch on the virus as well. The World Health Organization counts 1,003 human H5N1 infections since 2003, of which 479 ended in death, reported from 25 countries with India among them. Holding the virus down in chickens therefore does more than protect farm income: it shortens the route the virus can take to other animals and to human beings.

Important Facts

VaccineIndia's first indigenous inactivated H5N1 (Clade 2.3.2.1a) HPAI vaccine for chickens
Developed byICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal
To be dedicated byShivraj Singh Chouhan, Union Minister of Agriculture and Farmers Welfare and Rural Development
Place and dateICAR-NIHSAD, Bhopal, on 20 November 2026
DiseaseHighly Pathogenic Avian Influenza (HPAI), commonly called bird flu
Mortality in an infected flockClose to 100 per cent
First detected in India2006; more than 500 H5N1 and H5N8 outbreaks since then
Possible hit to GDP growthUp to 1.5 per cent in a major outbreak
Loss in the 2006 outbreakAn estimated Rs 2,200 to 3,000 crore, direct and indirect
WHO human tally1,003 cases and 479 deaths in 25 countries since 2003

Exam Point of View

Remember the institute (ICAR-NIHSAD, Bhopal), the clade (2.3.2.1a), the disease (Highly Pathogenic Avian Influenza or bird flu), the vaccine type (inactivated, for chickens), the minister (Shivraj Singh Chouhan), the year bird flu was first detected in India (2006) and the WHO tally of 1,003 human cases with 479 deaths in 25 countries since 2003.

Practice Questions

Q1.Science & TechnologyEasy

Which institute has developed India's first indigenous H5N1 (Clade 2.3.2.1a) vaccine for chickens?

  1. A.ICAR-Indian Veterinary Research Institute, Izatnagar
  2. B.ICAR-National Institute of High Security Animal Diseases, Bhopal
  3. C.National Institute of Virology, Pune
  4. D.ICAR-National Dairy Research Institute, Karnal
Show answer
Correct answer: B. ICAR-National Institute of High Security Animal Diseases, Bhopal

The inactivated vaccine for chickens against the H5N1 Clade 2.3.2.1a Highly Pathogenic Avian Influenza virus was developed indigenously at this Bhopal institute, usually shortened to ICAR-NIHSAD, and it is the first vaccine of its kind made in India against this clade.

Frequently Asked Questions

Which institute developed India's first indigenous H5N1 vaccine for chickens?

The ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal. Its inactivated vaccine targets the H5N1 Clade 2.3.2.1a strain of Highly Pathogenic Avian Influenza and is the first of its kind in India.

When and by whom will the H5N1 chicken vaccine be dedicated to the nation?

On 20 November 2026, by Union Minister of Agriculture and Farmers Welfare and Rural Development Shivraj Singh Chouhan, at the ICAR-NIHSAD campus in Bhopal, Madhya Pradesh.

Why does Clade 2.3.2.1a matter so much?

Most bird flu outbreaks in chickens have been traced to this clade, and no commercial vaccine existed specifically against it. The strain has lately been detected in mammals as well and in three human infections, which makes control in poultry a public health matter and not only a farm one.

Sources

Useful for:SSCSSC CGLIBPS